TRPC6 antagonists (Algomedix)

N/A

Report date: 2025/01/15 13:54:13
NME

Base Information

Drug NameTRPC6 antagonists (Algomedix)
Drug Alias NameALGX-2225ALGX-2224
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionShort transient receptor potential channel 6 inhibitors
TargetsShort transient receptor potential channel 6
Therapy Area/IndicationsCardiomegalyRenal Insufficiency, ChronicDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlgomedix Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlgomedix Inc
Inactive CompaniesN/A
Active IndicationsCardiomegalyRenal Insufficiency, ChronicDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A